Skip to content
healthcare.dev

Alogliptin

NDC 71610-661, Alogliptin, tablet, film coated, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-661
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022271
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-661 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALOGLIPTIN BENZOATE12.5 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
71610-661-09716100661099000 TABLET, FILM COATED in 1 BOTTLE (71610-661-09)
71610-661-18716100661183000 TABLET, FILM COATED in 1 BOTTLE (71610-661-18)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a05d6d17-79f9-4788-a4d5-467bca1a2d91

Use it

Look up 71610-661 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-661 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-661. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.